Background: |
Sodium-independent, high affinity transport of large neutral amino acids. Has narrower substrate selectivity compared to SLC7A5 and SLC7A8 and mainly transports branched-chain amino acids and phenylalanine. Plays a role in the development of human prostate cancer, from prostatic intraepithelial neoplasia to invasive prostate cancer. |
Applications: |
WB |
Name of antibody: |
SLC43A1 |
Immunogen: |
Synthesized peptide derived from internal of human LAT3. |
Full name: |
solute carrier family 43 (amino acid system L transporter), member 1 |
Synonyms: |
LAT3; PB39; POV1; R00504 |
SwissProt: |
O75387 |
WB Predicted band size: |
61 kDa |
WB Positive control: |
Jurkat cells and A549 cells lysates |
WB Recommended dilution: |
500-3000 |